Gene therapy, genome editing and diagnostics – where does the journey lead? Toni Cathomen, professor for cell and gene therapy at Freiburg University and director of the Institute for Transfusion Medicine and Gene Therapy at the University Medical Center, will also take a look at the future. Programmable nucleases like CRISPR-Cas have hailed a new era within personalized medicine. Prof. Cathomen will explain the principles of gene therapy and genome editing, present examples of successfully applied gene therapies for diseases of the blood and the immune system, and discuss new technologies for editing the genome, which have noticeably enlarged the application spectrum of gene therapy. He will end his presentation with a closer look at diagnostic assays used to assess, and where appropriate ameliorate, the risks of genotoxicity. The audience is invited to share his vision of the future of this field.
Though the topics are complex, it is a characteristic of the four-day event that all presentations are short, precise and easy to understand, and that rewarding discussions with the audience can be held on stage. This concept has contributed significantly to the success of the MEDICA LABMED FORUM as one of the highlights of the program at MEDICA.
MEDICA DEEP DIVE: Diagnostics of infectious diseases
For anyone interested in a more in-depth preparation for their visit of MEDICA, the digital, English-language talk rounds "MEDICA DEEP DIVE" are ideal. They will focus on particularly relevant trend topics in the healthcare sector. They will start on September 22 with a topic from the field of laboratory medicine: "Diagnostics of infectious diseases", with a focus on current innovations and developments in the field of point-of-care diagnostics.
For the latest information about the MEDICA LABMED FORUM program: https://www.medica-tradefair.com/mlf2.
Information on the topics, dates and participation in the MEDICA DEEP DIVE digital talk rounds is available at: https://www.medica-tradefair.com/en/MEDICA_DEEP_DIVE.
Author: Gabriele Brähler, health journalist (Berlin)
Back to HCB News
